Professor, Psychiatry, Perelman School of Medicine
Psychiatry
Dr. Michael E. Thase, MD
|
|
Give Review
Michael E. Thase works in the field of Psychiatry. He attended The Ohio State University College of Medicine. He received 6 awards: "Philadelphia Magazine", "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Pittsburgh Magazine", "Super Doctor" and "Whos Who in Medicine and Healthcare". Michael E. Thase is a published doctor. He published 100 publications, including: 'Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.'
Publications
- A tool to predict suicidal ideation and behavior in bipolar Disorder: The Concise Health Risk Tracking Self-Report.
- Convergence in patient-therapist therapeutic alliance ratings and its relation to outcome in chronic depression treatment.
- Assessing cognitive therapy skills comprehension, acquisition, and use by means of an independent observer version of the Skills of Cognitive Therapy (SoCT-IO).
- Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.
- Baseline disability and poor functioning in bipolar Disorder predict worse outcomes: results from the Bipolar CHOICE study.
- Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar Disorder.
- Improved cognitive content endures for 2 years among unstable responders to acute-phase cognitive therapy for recurrent Major depressive disorder.
- Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis.
- Effects of desvenlafaxine on blood pressure in patients treated for Major depressive disorder: a pooled analysis.
- Common and Dissociable Dysfunction of the Reward System in Bipolar and Unipolar Depression Reward Dysfunction in Depression.
- Medical burden in bipolar Disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
- Psychotherapy use in bipolar Disorder: Association with functioning and illness severity.
- Complexity of Illness and Adjunctive Benzodiazepine Use in Outpatients With Bipolar I or II Disorder: Results From the Bipolar CHOICE Study.
- Stable remission and recovery after acute-phase cognitive therapy for recurrent Major depressive disorder.
- The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar Disorder.
- Proceed with Caution: Off-label Ketamine Treatment for Major Depressive Disorder.
- The promise of cognitive behavior therapy for treatment of severe mental Disorders: a review of recent developments.
- Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of Major depressive disorder: a phase 4, randomized controlled trial.
- Mediators of Sexual Functioning and Marital Quality in Chronically Depressed Adults with and Without a History of Childhood Sexual Abuse.
- Computer-assisted cognitive behavioral therapy for pregnant women with Major depressive disorder.
- Improvement in self-reported quality of life with cognitive therapy for recurrent Major depressive disorder.
- Large-Scale Study Suggests Specific Indicators for Combined Cognitive Therapy and Pharmacotherapy in Major Depressive Disorder.
- Drug safety evaluation of olanzapine/fluoxetine combination.
- Desvenlafaxine for the treatment of Major depressive disorder.
- Efficacy of vilazodone on anxiety symptoms in patients with Major depressive disorder.
- A performance improvement initiative for enhancing the care of patients with depression.
- Corrigendum to "Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II Disorder: Results from the...
- Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II Disorder: results from the Bipolar CHOICE ...
- Computer-assisted cognitive-behavior therapy for depression.
- A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial.
- Efficacy and Safety of Olanzapine/Fluoxetine Combination Versus Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive...
- Translating clinical science into effective therapies.
- Extreme nonresponse to acute phase cognitive therapy for depression: an attempt to replicate and extend.
- Levomilnacipran: a newly approved drug for treatment of Major depressive disorder.
- Neural substrates of trait ruminations in depression.
- Pooled analysis of adjunct extended-release quetiapine fumarate in patients with Major depressive disorder according to ongoing SSRI or SNRI treatment.
- Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex Disorder.
- The prevalence and severity of Depressive symptoms along the spectrum of unipolar Depressive disorders: a post hoc analysis.
- Residual symptoms and the risk of relapse in Major depression.
- Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent Major depressive disorder treated with venlafaxine extended re...
- CLINICAL RELEVANCE OF FATIGUE AS A RESIDUAL SYMPTOM IN Major DEPRESSIVE DISORDER.
- Antidepressant combinations: cutting edge psychopharmacology or passing fad?
- Medication adherence in a comparative effectiveness trial for bipolar Disorder.
- Preventing Depressive Relapse and Recurrence in Higher-Risk Cognitive Therapy Responders: A Randomized Trial of Continuation Phase Cognitive Therapy, Fluoxetine, or Ma...
- Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor Depressive disorder.
- The cardiovascular safety profile of escitalopram.
- Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood Disorders.
- Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar Disorder.
- Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo con...
- The Medication Recommendation Tracking Form: A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness...
- Quetiapine XR monotherapy in Major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy.
- Antidepressant-induced excessive sweating: Clinical features and treatment with terazosin.
- Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).
- Association Between Therapeutic Alliance, Care Satisfaction, and Pharmacological Adherence in Bipolar Disorder.
- Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of Major depressive disorder (2006-2010).
- General medical burden in bipolar Disorder: findings from the LiTMUS comparative effectiveness trial.
- Monoamine oxidase inhibitors revisited: what you should know.
- Going Beyond Antidepressant Monotherapy for Incomplete Response in Nonpsychotic Late-Life Depression: A Critical Review.
- Do Menopausal Status and Use of Hormone Therapy Affect Antidepressant Treatment Response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STA...
- Lithium treatment moderate-dose use study (LiTMUS) for bipolar Disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and with...
- Impact of reproductive status and age on response of depressed women to cognitive therapy.
- Dysfunctional attitudes as a moderator of pharmacotherapy and psychotherapy for chronic depression.
- Acute phase cognitive therapy for recurrent Major depressive disorder: Who drops out and how much do patient skills influence response?
- Identifying psychiatrists' practice patterns when managing depression in patients with bipolar I Disorder: a descriptive study to inform education needs.
- Are we getting closer to valid translational models for Major depression?
- Extended release quetiapine fumarate in Major depressive disorder: analysis in patients with anxious depression.
- Social skills training for depression and comparative efficacy research: a 30-year retrospective.
- Applying antidepressant study results to clinical practice.
- Assessment of depressive symptoms and functional outcomes in patients with Major depressive disorder treated with duloxetine versus placebo: primary outcomes from two ...
- Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combin...
- The efficacy profile of vilazodone, a novel antidepressant for the treatment of Major depressive disorder.
- Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar Disorder.
- Dr Carpenter and colleagues reply.
- A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-sever...
- The Small Specific Effects of Antidepressants in Clinical Trials: What Do They Mean to Psychiatrists?
- Combined Antidepressant Strategies Are Not More Effective Than Vigorous Escitalopram Monotherapy: Results of the CO-MED Study.
- Intent-to-Treat Analysis of Health Care Expenditures of Patients Treated With Atypical Antipsychotics as Adjunctive Therapy in Depression.
- Sleep matters: Sleep functioning and course of illness in bipolar Disorder.
- Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
- ACP journal club. Cognitive-behavioral therapy reduced risk for recurrence in patients recently hospitalized with cardiovascular disease events.
- Treatment-resistant depression: prevalence, risk factors, and treatment strategies.
- Remission prognosis for cognitive therapy for recurrent depression using the pupil: utility and neural correlates.
- Pharmacotherapy for the treatment of acute bipolar II depression: current evidence.
- Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complet...
- Skills of Cognitive Therapy (SoCT): A new measure of patients' comprehension and use.
- The role of neurobiologic processes in symptoms of depression.
- An open label pilot study of transcranial magnetic stimulation for pregnant women with Major depressive disorder.
- Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar Disorder: findings from the Systematic Treatment Enhancement Program for...
- Lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity Disorder in adults with a history of depression or history of substance use Disorder.
- Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant Major depression in clinical practice after FDA approval: outcomes at 1 year.
- Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label study.
- The clinical management of bipolar Disorder: a review of evidence-based guidelines.
- A quality-based review of randomized controlled trials of psychodynamic psychotherapy.
- Transition to mania during treatment of bipolar depression.
- The role of quetiapine extended release in the treatment of bipolar depression.
- The role of neurobiologic processes in treating depression.
- Performance improvement CME: improving outcomes in depression.
- Desvenlafaxine and escitalopram for the treatment of postmenopausal women with Major depressive disorder.
- The influence of menopause status and postmenopausal use of hormone therapy on presentation of Major depression in women.
Schools
Ohio State University College of Medicine
Hospital University Health Center
Western Psychology Institute Clin
University Pittsburg School Med
Conditions Treated
- Major Depressive Disorder
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- Philadelphia Magazine
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Pittsburgh Magazine
- Super Doctor
- Whos Who in Medicine and Healthcare
Education
-
University of Pittsburgh Medical Center -
The Ohio State University College of Medicine
Hospital
-
Hospital of the University of Pennsylvania
Helpful Reviews
Similar Doctors
|
|
Dr. Lillian G. Reilly, DO |
|
|
Dr. David G. Prado, DO |
|
|
Dr. Linda S. Altman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur B. Weisberg, MD |
|
|
Dr. Grace Jones, DO |
|
|
Dr. Claudia M. Sauerteig, MD |
|
|
Dr. Alexandra S. Macy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sachin Mehta, MD |
|
|
Dr. Peter T. Swanljung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allan H. Cristol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamado S. Musthaq, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Humra Mahmood, MD |
|
|
Dr. Neal R. Satten, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roy K. Augusthy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman C. Jablon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valerie J. Nordquist, MD
This Doctor is OpenDoctor Recommended.
|